Exact Sciences CEO and Chair Kevin Conroy discusses the company's new multi-cancer blood test and competitive environment. Speaking on "Bloomberg Open Interest," Conroy also comments on President Donald Trump's view that companies should report earnings every six months.
Exact Sciences CEO on Launch of Multi

121